If you are a professional stock trader or if you track the equity market actively, check out our Real-time EquityWireIf you track the bond or forex market or the macro economy actively, check out our Real-time MoneyWireIf you track agri commodities, precious metals or base metals actively, check out our Real-time CommodityWire
The division bench of the Delhi High Court has set aside its single-judge bench order restraining Rebanta Healthcare Pvt Ltd from using the name "Rebaheal" for its medicine used for treatment of pain. A single-judge bench in July had passed the ex-parte interim order in a trademark infringement suit filed by Dr Reddy's Laboratories Ltd against Rebanta.
Share this Story:
